Bio Usawa Biotechnology and ServareGMP Form Strategic Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa
KIGALI, Rwanda and SAN FRANCISCO and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa) and ServareGMP (Servare) today announced a strategic partnership to establish advanced monoclonal antibody manufacturing capabilities in Africa, directly addressing the critical healthcare access gap affecting patients in low- and middle-income countries (LMICs).
This transformative collaboration spans four core pillars:
Local Biomanufacturing Infrastructure: Building and operating advanced GMP manufacturing facilities in Africa for the production of high-quality monoclonal antibodies.
Workforce Development & Training: Implementing industry-leading training programs to cultivate a skilled biopharma workforce across the continent.
Process Innovation: Deploying next-generation process optimization and cost-reduction technologies to make antibody therapies more affordable.
Emergency Response Capability: Establishing rapid development and deployment protocols for mAbs to respond to pandemics and regional health crises.
Leveraging Industry-Leading Expertise for Healthcare Transformation
The partnership combines Bio Usawa's deep understanding of African healthcare markets with Servare's extensive biopharmaceutical development expertise. Together, the organizations bring decades of proven experience across biotherapeutic development, clinical testing, current Good Manufacturing Practice (cGMP), regulatory approvals, and global commercialization of breakthrough biomedicines, including many of the leading blockbuster therapies on the market today.
This collaboration is grounded in a shared commitment to addressing the growing therapeutic access disparity in LMICs. The partnership's strategic focus aligns with recent initiatives by both organizations: Servare's collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop countermeasures against the Nipah virus, and Bio Usawa's partnership with Bioeq AG for BioUcenta, a biosimilar of Lucentis® targeting retinopathies in Sub-Saharan Africa.
'ServareGMP was founded on the belief that world-class biomanufacturing should be globally distributed,' said Gary Pierce, Executive Director of ServareGMP. "Through this collaboration, we are not only addressing immediate healthcare needs but also building sustainable infrastructure that will benefit future generations of African patients. Together, we will impact African healthcare by empowering communities and saving lives.'
'This initiative is about more than medicine—it's about building self-reliance, equity, and resilience,' said Richard Chin, M.D., Bio Usawa's co-founder and Chair of the Board of Directors. 'We are proud to co-create a future in which life-saving therapies are widely available at an affordable price for patients in Africa and in other LMICs. We are building the foundation for a more just and resilient global healthcare system.'
A Model for Global Health Equity
The partnership extends beyond cost reduction to fundamentally restructure how biotherapeutics are developed, produced, and delivered in LMICs. By investing in local talent, infrastructure, and innovation, the partnership seeks to ensure that patients in Africa can access the same life-saving therapies as those in high-income countries—both during crises and for ongoing care.
About Biotherapeutic Access in LMICs
Monoclonal antibodies are a cornerstone of modern medicine. However, cost and access barriers prevent their widespread use in many LMICs. This partnership will change that by enabling local production and distribution—cutting costs, reducing reliance on imports, and improving response times in health emergencies.
About Bio Usawa Biotechnology
Bio Usawa is a leading African biotechnology company dedicated to expanding access to affordable, high-quality biosimilars across the continent. Through strategic industry partnerships and deep regional expertise, Bio Usawa is pioneering a future where life-saving biomedicines are developed, manufactured, and distributed by Africans, for Africans—and beyond.
For more information, visit www.biousawa.com.
About ServareGMP
ServareGMP is a specialized non-profit biotechnology organization founded by industry veterans with extensive experience across the biopharmaceutical value chain. The organization's leadership team brings proven expertise spanning discovery, development, manufacturing, regulatory approval, and commercialization of innovative therapeutics.
For more information, visit www.servaregmp.com.
Media Contacts:For Bio Usawa: Daniel LevineLevine Media Group+1 510-280-5405danny@levinemediagroup.com
For ServareGMP:Enrique Cowenecowen@servarebiologics.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Are you as financially literate as a high school student? Take our quiz.
You might think you know a lot about credit and banking, taxes and insurance. Four teenagers from Scripps Ranch High School probably know more. A four-student team from the San Diego school won the 2025 National Personal Finance Challenge, a financial literacy contest that ended in June in Atlanta. If you feel like testing your own financial literacy, take our 10-question quiz, below. It's an abbreviated version of the contest's final round. But first, take a minute to read about how the San Diego students won. The event, which started with nearly 18,000 students, is part of a national campaign to encourage personal finance study in school. It seems to be working: 38 states now require personal finance for graduation, up from 23 states in 2022. 'This is a real discipline with a real set of things you need to know,' said Christopher Caltabiano, chief program officer at the Council for Economic Education, which runs the contest. 'This is stuff you use every single day of your life.' What is 'negative equity'? These students knew. For the Scripps Ranch students, the trip to Atlanta ended in high drama. They won the contest by a single point, edging out a talented team from Mount Hebron High School in Ellicott City, Maryland. Scripps Ranch would have lost by a point. The team persuaded contest judges to change their minds on two quiz questions it had missed. One question asked for the term for a home or car loan whose balance exceeds what the asset is worth. The team's answer was 'negative equity,' which is correct. But the judges were looking for 'upside down,' which is a colloquial term for negative equity. 'So, initially, they didn't give it to us,' said Robert Schumann, 17, who is a rising Scripps Ranch senior this fall. 'From what we've seen, nobody has ever won a challenge, so we were stressing out a little bit that we got it incorrect.' The second challenge came on this question: What is the first thing you should do if you think you're the victim of a scam? Freeze your assets, the Scripps Ranch team replied. The correct answer: Call your bank. 'We said it's kind of inferred that you'd call your bank,' whose first move would be to freeze your assets, Schumann said. The judges ultimately agreed. They learned financial literacy from YouTube and AI Scripps Ranch High sits in California, one of the states that now require personal finance education. But the mandate doesn't take effect until 2027. 'These students really self-learned and self-taught themselves,' said Ian Rasmuson, a Scripps Ranch teacher who coached the winning team. Rasmuson himself teaches history. Students revived the school's idle entrepreneurship club last year, hoping to invite guest speakers to talk about business and finance. 'We kind of just wanted to teach people about these topics,' said Ryan Langsam Williams, 17, a rising senior who joined the team. 'What I had in mind was to do competitions like these, and to have everyone in the club involved.' He found the National Personal Finance Challenge online. To prepare, the team reviewed coursework on the Council for Economic Education website, studied past contests, watched YouTube videos and used AI to generate practice quizzes. 'We don't have a personal finance class at our school,' Schumann said. Take a 10-question quiz from the Personal Finance Challenge Here are 10 questions from the final round of the 2025 National Personal Finance Challenge. You'll find the answers below. 'I think you should feel pretty darn good about yourself if you get seven out of 10,' Caltabiano said. What is the term given to the amount in an account that is separate from any earnings or interest that has accrued? What is the name given to a digital credential that allows users to sign in to apps and websites without using a password? Insurance companies evaluate risk for the purpose of issuing insurance coverage. This process is called what? A system where people earn money by providing services or goods on demand, usually through digital platforms, is called what kind of economy? What credit card transaction requires you to pay interest every day, including the first day of the transaction, until it is repaid in full? On your way to work, you get caught in a hailstorm that damages your car. What type of car insurance covers the damage? Steven contributes pretax dollars to an account managed by his employer for his health care expenses. If he does not spend all of his money by the end of the year, he will forfeit it. What kind of plan does he have? Fred does not believe in banks and keeps his money in a sock buried in the backyard, under a new concrete patio. He faces little risk of having the money stolen, but his sock money is subject to what kind of risk? You buy bonds from a corporation and notice that the company can buy the outstanding bonds from you before the maturity date. What is this feature called? What is the name given to a stock that pays a higher-than-average dividend? The answers: 1) Principal. 2) Passkey. 3) Underwriting. 4) Gig. 5) A cash advance. 6) Comprehensive. 7) A Flexible Spending Account. 8) Inflation risk. 9) A call feature. 10) Income stock. This article originally appeared on USA TODAY: Are you as financially literate as a high school kid? Take our quiz. Sign in to access your portfolio
New York Times
an hour ago
- New York Times
A Day at Two San Francisco Malls, One That Died and One That Thrived
For years, San Francisco Centre was a destination, an anchor of a buoyant downtown that seemed destined to keep on booming. Shoppers rode circular escalators up to Nordstrom to buy expensive shoes while a musician played a grand piano. When an even fancier Bloomingdale's opened there in 2006, California's first lady, Maria Shriver, cut a ribbon carried by aerial dancers. A few miles west and another world away, out toward the ocean and low-slung single family homes, Stonestown Galleria sat forlorn. It was your typical suburban-style mall, though still in the city limits, with a run-down movie theater and unlimited breadsticks at the Olive Garden. If the first lady ever went there, she did not brag about it. Then, their fortunes reversed. The downtown mall, long referred to as Westfield Centre for one of its owners, became a national symbol of the city's pandemic-battered downtown. It lost its movie theater, its day spa and nearly all of its stores. Its Nordstrom and Bloomingdale's anchors are gone. It even lost its name when Westfield Corporation, the shopping mall firm, abandoned the space in June 2023. The 1.5 million square foot behemoth has lost $1 billion in value and is being held in receivership. It is scheduled to be put up for auction later this month. It remains open with a handful of stores still operating but is a shadow of its former self. Stonestown, on the other hand, has become 800,000 square feet of fun. People wait two hours for tables at its most popular restaurants. It is often hard to find an empty parking space in a sea of 3,800 of them. Some tourists head there straight from the airport. Want all of The Times? Subscribe.
Medscape
5 hours ago
- Medscape
Time Your Meals, Tune Your Metabolism
New research from UC San Diego has revealed fascinating insights into how timing our meals might significantly affect our metabolic health by aligning with our body's natural microbial rhythms. Just as our bodies follow circadian rhythms, our gut microbes have their own daily patterns, with certain beneficial activities increasing during our active periods to help with digestion and metabolism. The study found that unrestricted access to high-fat foods disrupted these natural patterns, leading to unusual daytime eating and metabolic dysfunction — similar to what human shift workers experience when their eating cycles don't match their biological clocks. Using cutting-edge metatranscriptomics technology, researchers identified a specific enzyme called bile salt hydrolase that plays a crucial role in metabolic improvements. When engineered into beneficial bacteria, this led to increased lean muscle mass, reduced body fat, and better blood glucose regulation. These findings could potentially lead to new targeted therapies for common metabolic disorders, offering hope for those struggling with obesity and diabetes. This breakthrough not only demonstrates the significant influence of circadian rhythms on microbial function, but it also provides a new method for testing how specific microbial activities affect our metabolism through engineered gut bacteria. This content was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
